Cardiosense, Inc., Completes $15.1 Million Series A Financing To Advance Artificial Intelligence Platform For Heart Disease
Amount Raised
$15.1 Million
Round Type
Series A
ChicagoHealth CareInvestors
Description
Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection of cardiovascular disease, announced today that it has raised $15.1 million in Series A funding, co-led by Broadview Ventures and Hatteras Venture Partners, with participation from Laerdal Million Lives Fund, OSF Ventures, UnityPoint Health Ventures, and Portal Innovations. The capital will be used to support team expansion, accelerate product development, and fund an expansive heart failure study.
Quick answer
Cardiosense raised $15.1 Million in a Series A round, dated December 8, 2022. Investors: Unity Point Health Ventures, OSF Ventures, Laerdal Million Lives Fund, Hatteras Venture Partners and Broadview Ventures. Cardiosense is based in Chicago, Illinois, United States.
- How much did Cardiosense raise?
- Cardiosense raised $15.1 Million in a Series A round on December 8, 2022.
- Who invested in Cardiosense?
- Unity Point Health Ventures, OSF Ventures, Laerdal Million Lives Fund, Hatteras Venture Partners and Broadview Ventures are named as investors in this round.
- What does Cardiosense do?
- Cardiosense is building a physiological waveform AI platform to develop predictive biomarkers to detect and manage cardiac disease.
- Where is Cardiosense based and how big is it?
- Cardiosense is based in Chicago, Illinois, United States. Fundz records about 38 employees.
Source: Fundz verified event record.
Who else raised in Health Care around the same time
Companies in the same sectors as Cardiosense that raised within 45 days of this round, from Fundz verified event records.
- Aneuvo raised $200K (Pre-Seed) on January 20, 2023.
- Miach Orthopaedics raised $40M on January 20, 2023.
- ADARx Pharmaceuticals, Inc. raised $46M (Funding Round) on January 20, 2023.
- Eppin Pharma raised an undisclosed amount (Funding Round) on January 19, 2023.
- Dentive raised an undisclosed amount on January 19, 2023.
- Breathe Well-being raised $6.1M (Funding Round) on January 19, 2023.
Who to call at Cardiosense, and when
A new round usually means Cardiosense is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cardiosense raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cardiosense, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cardiosense. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cardiosense raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansCardiosense raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.